Search results
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 1 month agoTakeda Pharmaceutical Co. Ltd. (NYSE:TAK) is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins...
Takeda Pharmaceutical Co. (TAK) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 2 months agoTakeda Pharmaceutical Co. (TAK) might move higher on growing optimism about its earnings prospects,...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript May 11, 2023...
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
Motley Fool· 9 months agoIf you're looking for a high-yield dividend stock in the healthcare sector, you might be interested...
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
The Wall Street Journal· 2 weeks agoHEALTH Takeda Pharmaceutical reported a fourth-quarter loss and forecast a drop in annual net profit...
Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse
Reuters via Yahoo News· 9 months agoDrugmakers have begun shipping copycat versions of Takeda Pharmaceutical's drug Vyvanse, which is...
Japan's Takeda slashes full-year profit forecast on drug pipeline impairments
Reuters via Yahoo News· 7 months agoTOKYO (Reuters) -Japan's biggest drugmaker Takeda Pharmaceutical on Thursday slashed its full-year...
Japan's Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine
Reuters via Yahoo Finance· 10 months agoTOKYO (Reuters) -Japan's Takeda Pharmaceutical posted first-quarter profit that beat analysts'...
Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now?
Zacks via Yahoo Finance· 2 years agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and...
Takeda pays $300M to license Protagonist drug for blood disorder
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: Protagonist Therapeutics, a biotechnology company focused on peptide drugs, is teaming...